I think its up for the rest of us to acknowledge that this is a new sign we get in large scale clinical development, but its really linked to the potency of the product. CagriSema is moving into a Phase III trial called REDEFINE 11, where Novo will examine a longer duration, dose escalation and dose re-escalation
Park J, Park S, Choi J, Han M, Lee Y
Glutathione deficiency may promote cancer initiation (by failing to protect DNA from oxidative damage), while elevated glutathione in established tumors may promote cancer progression and treatment resistance (by protecting cancer cells from chemotherapy and radiation) [2][5]
It helps smooth skin, soften rough patches, and support a healthy moisture barrier as an emollient
PMID 17327526
EC 2.5.1.18) are part of a superfamily of enzymes that play a crucial role in cellular detoxification